Target intelligence / Profile preview

Immune cells and immune mediators

Molecular classification
Other
01

Overview

Immune cells and immune mediators represent the collective cellular and molecular elements of the immune system responsible for host defense and tissue homeostasis. This broad category includes various leukocyte populations—such as T cells, B cells, natural killer cells, and macrophages—alongside the signaling molecules they secrete, including cytokines, chemokines, and interferons (StatPearls, 2023; NIH, 2024). These components coordinate complex responses to pathogens, toxins, and malignant cells through intricate signaling networks. In clinical medicine, dysregulation of these mediators is central to the pathogenesis of autoimmune disorders, chronic inflammation, and cancer progression (PubMed, 2023). While many drugs are designed to modulate specific pathways within this system, the term itself describes a functional network rather than a single druggable molecule. Consequently, therapeutic interventions targeting this system must be highly specific to avoid broad-spectrum immunosuppression or off-target inflammatory effects.

Other names
Immune system componentsLeukocytes and cytokinesInflammatory mediatorsImmunological factors
02

Mechanism of action

Inhibition of cytokine signaling, depletion of specific cell populations, blockade of immune checkpoints, and modulation of intracellular signaling pathways.

03

Biological functions

Immune responseInflammationHost defenseCell signalingHomeostasis
04

Disease associations

Autoimmune diseaseCancerInfectionInflammationAllergyGraft-versus-host disease
05

Safety considerations

Increased susceptibility to infectionsCytokine release syndrome (CRS)Infusion-related reactionsImmune-related adverse events (irAEs)Secondary malignancies
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Erythrocyte sedimentation rate (ESR)Cytokine levels (e.g., IL-6, TNF-alpha)Cell surface markers (e.g., CD4, CD8, CD20)Absolute neutrophil count (ANC)

Beyond the preview

Go deeper on Immune cells and immune mediators.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune cells and immune mediators.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call